GlassScriptPhysician profile
Ryan M Kauffman
NPI 1881873271
$4,829.57
in general payments reported to CMS, 2019-2025
29 companies · $1,172 in 2025
The $1,172 reported for 2025 was more than what 82% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $632 · 2020: $397 · 2021: $284 · 2022: $702 · 2023: $668 · 2024: $974 · 2025: $1,172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,624 · Education: $191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,623.79 |
| Education | $190.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $988.86 | 2022-2025 | |
| Optinose US, INC. | $646.18 | 2019-2025 | |
| Glaxosmithkline, LLC. | $428.14 | 2022-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $382.90 | 2022-2025 | Dupixent |
| Intersect Ent, INC. | $363.18 | 2019-2021 | |
| Medtronic, INC. | $307.65 | 2022-2025 | Propel, Sinuva, Stealthstation S8 Platform |
| Acclarent, INC | $200.36 | 2019-2023 | Acclarent Balloon Inflation Device |
| Hikma Pharmaceuticals USA | $183.48 | 2022-2024 | Ryaltris |
| Aerin Medical INC. | $169.16 | 2019-2024 | |
| Integra Lifesciences Corporation | $150.00 | 2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Stryker Corporation | $149.31 | 2019-2025 | Scopis Ent |
| Kaleo, INC. | $148.41 | 2019-2024 | Auvi-Q |
| Sanofi-Aventis U.S. LLC | $98.99 | 2024 | |
| Alk-Abello, INC | $83.52 | 2019-2022 | |
| Itamar Medical INC | $78.12 | 2024 | Watchpatone |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $65.66 | 2025 | Tezspire |
| Ars Pharmaceuticals Operations, INC. | $58.47 | 2025 | Neffy |
| Neurent Medical Limited | $51.43 | 2023-2025 | Neuromark Radiofrequency Console, Neuromark Device, Neuromark System |
| Fortovia Therapeutics, INC. | $48.49 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $43.10 | 2021-2023 | |
| Paratek Pharmaceuticals, INC. | $27.34 | 2025 | Xhance |
| Ethicon US, LLC | $26.61 | 2020-2021 | |
| Inspire Medical Systems, INC. | $26.12 | 2023 | Inspire |
| Astrazeneca Pharmaceuticals LP | $25.49 | 2025 | |
| Hologic Sales and Service, LLC | $21.91 | 2025 | Coolseal Generator |
| Teva Pharmaceuticals USA, INC. | $16.80 | 2022 | |
| Phadia US INC. | $14.39 | 2023 | Immunocap |
| Olympus America INC. | $12.80 | 2023 | Rhino-Laryngo Videoscope |
| Cochlear Americas | $12.70 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Kauffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.